Lincoln Pharmaceuticals Ltd (LINCOLN) — Board Meeting | 29 August 2026 (2 announcements)

29 August 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Board Meeting🟡 Notable Neutral📄 PDF

📢 Key Event

AGM scheduled to approve final dividend

💡 Investor Takeaway

Shareholders must attend the AGM to approve the dividend before it becomes payable.

Lincoln Pharmaceuticals announced its 32nd Annual General Meeting on September 30, 2026, to approve an 18% final dividend of ₹1.80 per share, triggering a book closure from September 12 to September 30, 2026, to determine record date eligibility for dividend payment.

2Board Meeting🟡 Notable Neutral📄 PDF

📢 Key Event

Final dividend of ₹1.80 per share proposed for FY 2025-26

💡 Investor Takeaway

Shareholders must hold shares by September 11 to qualify for the dividend payout.

Lincoln Pharmaceuticals announced a final dividend of 18% (₹1.80 per share) payable after approval at its September 30, 2026 AGM, with record date set for September 11, 2026 and book closure from September 12 to 30, 2026.

📊 Stock Analysis — LINCOLN ✨ Ask AI About This

About Lincoln Pharmaceuticals Ltd (LINCOLN)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,174.34 CrP/E: 12.2ROE: 12.7%ROCE: 16.9%Div Yield: 0.31%

View full LINCOLN stock details →

📡 Get AI alerts when LINCOLN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LINCOLN — Free

💡 Ask AI about this filing

"When will the dividend be credited to eligible shareholders?""What is the record date for dividend entitlement?""How does this dividend yield compare to peers?"

Ask AI Free →

📊 More LINCOLN filings

🔴 Announcement — 24 September 2026Lincoln Pharmaceuticals announced the appointment of Pradeep Kumar Yadav as Senior General Manager-Q...
🔴 Announcement — 24 September 2026Lincoln Pharmaceuticals announced the resignation of Mr. Manoj Rai, Sr. General Manager- QA (Head QA...
Announcement — 23 September 2026Lincoln Pharmaceuticals has announced that its trading window will close on October 1, 2026, and rem...
🔴 Annual Report — 5 September 2026Lincoln Pharmaceuticals reported FY2025-26 revenue of **₹671.03 crores**, EBITDA of **[amount contex...
🟡 Board Meeting — 5 September 2026Lincoln Pharmaceuticals announced its 32nd Annual General Meeting will be held on September 30, 2026...

See all LINCOLN filings →

🔥 Also filed on 29 August 2026

AARTIPHARMAarti Pharmalabs LtdAnnual Report FUSIONFusion Finance LtdCorporate Action AKSHARCHEMAksharChem (India) LtdCorporate Action SPALS P Apparels LtdInsider Trading DHARMAJDharmaj Crop Guard LtdAnnual Report 512271Tashi India LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LINCOLN files new disclosures

Track LINCOLN filings, board meetings, and corporate actions. Free email alerts at 5 PM.